3 ms·
If it prevents someone from dying, or even reduces ICU or hospital stay by one day, then it's worth it for that person at least. It's a windfall for Merck (and
by musicale 5y ago
If it prevents someone from dying, or even reduces ICU or hospital stay by one day, then it's worth it for that person at least.
It's a windfall for Merck (and their shareholders) but I could still imagine it saving tons of money for taxpayers and people who pay for health insurance.
- alistairSH 5y agoThe problem is paying for the drug. We lack socialized healthcare in the US. How many people will forgo treatment because they don't have $700+ for a pill. By the time the patient is in bad enough shape to be willing to beg/borrow/steal $700, it's too late for the treatment to be effective.